Abstract

S A T A b st ra ct s p = 0.0006) were identified as independent predictors for worse OS. Conclusion: When the prognostic impacts of perioperative serum CA19-9, SPan-1 and DUPAN II levels in patients with resectable PDAC were compared, elevated postoperative CA19-9 (> 37 IU/ml) would be the strongest predictive marker of poor survival in the perioperative period, which may contribute to establishment of new therapeutic strategy.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call